Welcome to our dedicated page for Gohealth news (Ticker: GOCO), a resource for investors and traders seeking the latest updates and insights on Gohealth stock.
GoHealth, Inc. reports developments in its Medicare-focused health insurance marketplace, where proprietary technology and licensed agents support consumer plan comparison and enrollment. News about GOCO commonly covers Medicare Advantage market conditions, Annual Enrollment Period activity, PlanFit technology, Special Needs Plans, retention initiatives, and the company’s efforts to match consumers with coverage suited to their needs.
Company updates also address quarterly and annual results, revenue mix, commission receivables, back-book durability, liquidity, cost discipline, automation and AI investments, and capital or governance actions. Recent coverage has emphasized a more disciplined Medicare Advantage posture, member quality, renewal economics, and strategic flexibility.
GoHealth, Inc. (NASDAQ: GOCO) reported Q1 2024 financial results with net revenues of $185.6 million, a slight increase year-over-year. Submissions increased to 216,148. Net loss improved to $21.3 million. Adjusted EBITDA decreased to $26.9 million. TTM cash flow from operations grew to $101.2 million. Regulatory updates show alignment with CMS guidelines. CEO and CFO optimistic about consumer-centric approach and long-term profitability.
GoHealth, Inc. to present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024, at 2:05 p.m. Eastern Time. The presentation will be accessible via a live webcast and a replay will be available on GoHealth's Investor Relations website.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.